The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer-Reference-Cited by-同舟云学术

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer

Published:2018-10-24 Issue:11 Volume:119 Page:1383-1391
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Bertucci François,Finetti Pascal,Simeone Ines,Hendrickx Wouter,Wang Ena,Marincola Francesco M.,Viens Patrice,Mamessier Emilie,Ceccarelli Michele,Birnbaum Daniel,Bedognetti Davide

Funder

Ligue Contre le Cancer

SIRIC

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-018-0309-1.pdf

Reference43 articles.

1. Sotiriou, C. & Pusztai, L. Gene-expression signatures in breast cancer. N. Engl. J. Med. 360, 790–800 (2009).

2. Parker, J. S. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160–1167 (2009).

3. Sabatier, R., Goncalves, A. & Bertucci, F. Personalized medicine: present and future of breast cancer management. Crit. Rev. Oncol. Hematol. 91, 223–233 (2014).

4. Zitvogel, L., Tesniere, A. & Kroemer, G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat. Rev. Immunol. 6, 715–727 (2006).

5. Galon, J., Angell, H. K., Bedognetti, D. & Marincola, F. M. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity 39, 11–26 (2013).

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of GZMA as a target of cysteine and biomarker in Alzheimer’s disease, pelvic organ prolapse, and tumor progression;Frontiers in Pharmacology;2024-08-20

2. Integrated immuno-transcriptomic analysis of ovarian cancer identifies a four-chemokine-dominated subtype with antitumor immune-active phenotype and favorable prognosis;British Journal of Cancer;2024-08-02

3. Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma;Nature Communications;2024-03-22

4. Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer;Frontiers in Immunology;2024-02-05

5. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for immune checkpoint inhibitors in advanced biliary tract cancer;2024-01-10